Tuesday, February 24, 2009

Asbestos Exposure For Those In The Shipping Industry

Asbestos exposure was common among industrial workers. Among the more common jobsites were those in the shipbuilding industry, such as the Todd Shipyards or Newport News Naval Shipyard. Other jobsites include power plants, chemical manufacturing, or the metal works industry. Those with asbestos history should notify their doctor and learn of possible warning signs of health complications caused by exposure.

Saturday, February 7, 2009

How is Mesothelioma Diagnosed?

Malignant mesothelioma can be difficult to diagnose because symptoms of the disease often closely mimic those of less serious conditions. It will often require X-ray and other body scans (CT or MRI) in addition to a biopsy to conclusively diagnose mesothelioma. Nevertheless, those experiencing chronic cough, difficulty swallowing, chest pain, or breathing difficulties should alert their physician immediately. This is particularly true among those with a known asbestos-exposure history. Those with asbestos exposure history should communicate this to their physician even before symptoms appear so that they may be able to alert patients to warning signs of the disease. If detected early enough, patients may be eligible for aggressive treatment options, including surgical resection of the mesothelioma cancer and affected tissue. Oncologists and thoracic specialists will be able to assist the patient in determining the extent of the disease and the best treatment options for that particular patient.

How is Mesothelioma Treated?

Mesothelioma is an aggressive cancer but can be managed with chemotherapy, radiation therapy, and surgery. Currently, there is no known cure for asbestos cancer but several mesothelioma treatment regimens have proven to be successful in helping the patient avoid pain and discomfort caused by the disease. Several therapies have emerged in recent years that have extended survival rates to levels previously thought to be impossible. Cancer centers have initiated hundreds of clinical trials in recent years to help mesothelioma patients find a therapy that works for them while still working towards a cure for future patients. Progressive therapies are now being developed through the International Mesothelioma Program under the direction of thoracic specialist Dr. David Sugarbaker.